§1680q — Title 25 Indians | U.S. Code

Summary

The Secretary, working with the Secretary of the Interior and the Attorney General, must create a prescription drug monitoring program to operate in Service health centers, tribal health clinics, and urban Indian health centers. Within 18 months after March 23, 2010, the Secretary must send a report to the Senate Committee on Indian Affairs and the House Committee on Natural Resources describing what those facilities need for the program, how the program will be built (including any legal or administrative limits), and how it could link up with State prescription drug monitoring systems. The Attorney General, with the same two Secretaries, must assess whether federal and tribal agencies can collect and analyze data on prescription drug abuse in Indian communities, share that information, and what support is needed. They must also provide training for health providers, tribal leaders, law enforcement, and school officials on awareness, prevention, and better responses. Within 18 months after March 23, 2010, the Attorney General must report to the same two Congressional committees on agency capacity, the training done, any needed infrastructure upgrades, and any legal or administrative barriers.

Title 25, §1680q

Indians — Source: USLM XML via OLRC

(a)(1)The Secretary, in coordination with the Secretary of the Interior and the Attorney General, shall establish a prescription drug monitoring program, to be carried out at health care facilities of the Service, tribal health care facilities, and urban Indian health care facilities.

(2)Not later than 18 months after March 23, 2010, the Secretary shall submit to the Committee on Indian Affairs of the Senate and the Committee on Natural Resources of the House of Representatives a report that describes—

(A)the needs of the Service, tribal health care facilities, and urban Indian health care facilities with respect to the prescription drug monitoring program under paragraph (1);

(B)the planned development of that program, including any relevant statutory or administrative limitations; and

(C)the means by which the program could be carried out in coordination with any State prescription drug monitoring program.

(b)(1)The Attorney General, in conjunction with the Secretary and the Secretary of the Interior, shall conduct—

(A)an assessment of the capacity of, and support required by, relevant Federal and tribal agencies—

(i)to carry out data collection and analysis regarding incidents of prescription drug abuse in Indian communities; and

(ii)to exchange among those agencies and Indian health programs information relating to prescription drug abuse in Indian communities, including statutory and administrative requirements and limitations relating to that abuse; and

(B)training for Indian health care providers, tribal leaders, law enforcement officers, and school officials regarding awareness and prevention of prescription drug abuse and strategies for improving agency responses to addressing prescription drug abuse in Indian communities.

(2)Not later than 18 months after March 23, 2010, the Attorney General shall submit to the Committee on Indian Affairs of the Senate and the Committee on Natural Resources of the House of Representatives a report that describes—

(A)the capacity of Federal and tribal agencies to carry out data collection and analysis and information exchanges as described in paragraph (1)(A);

(B)the training conducted pursuant to paragraph (1)(B);

(C)infrastructure enhancements required to carry out the activities described in paragraph (1), if any; and

(D)any statutory or administrative barriers to carrying out those activities.

Editorial Notes

Codification section 827 of Pub. L. 94–437 is based on section 196 of title I of S. 1790, One Hundred Eleventh Congress, as reported by the Committee on Indian Affairs of the Senate in Dec. 2009, which was enacted into law by section 10221(a) of Pub. L. 111–148.

§1680q Prescription drug monitoring

Summary

Title 25, §1680q

Notes & Related Subsidiaries

Editorial Notes

Citations & Metadata